Investor Relations

Investor FAQs

 

Agile Therapeutics common stock is traded on the NASDAQ Global Market
Ticker Symbol: AGRX

101 Poor Farm Road
Princeton, New Jersey 08540

December 31

Broadridge Corporate Issuer Solutions, Inc.
PO Box 1342
Brentwood NY 11717
Email: shareholder@broadridge.com

Phone: 866-321-8022 (Toll free); 720-378-5956 (Toll).
Call Center Support hours: 9:00 am - 6:00 pm ET.

Broadridge Corporate Issuer Solutions, Inc.
PO Box 1342
Brentwood NY 11717
Email: shareholder@broadridge.com

Phone: 866-321-8022 (Toll free); 720-378-5956 (Toll).
Call Center Support hours: 9:00 am - 6:00 pm ET.

Regular Mail Communication items should be sent to:
Broadridge Corporate Issuer Solutions, Inc.
PO Box 1342
Brentwood NY 11717

Overnight Mail Communication items should be sent to:
Broadridge Corporate Issuer Solutions, Inc.
ATTN: IWS
1155 Long Island Avenue
Edgewood NY 11717

No, Agile Therapeutics does not have a direct stock purchase plan. Shares may be purchased through a financial services provider of your choice.

Please visit the Financial Information pages of the Investor Relations section of our Web site or refer to the most recent 10-Q or 10-K report under the heading "SEC Filings."

Please visit the Investor Relations section of our Web site and choose the "Email Alerts" tab to be added to the Agile Therapeutics distribution list.

Please submit your question using the form below.

* Indicates required field